Interestingly, our results reveal a down-regulation of TGFβ1 and an up-regulation of TGFβ2, TGFβ3, Smad4 and RAC1b in treated cells, suggesting that PRP treatment promotes the TGFβ pathway role via a tumour suppressive route. The gene discussed is TGFB3; the disease is neoplasm.